The Scientist

» HIV vaccine

Most Recent

image: Broadly Neutralizing Antibodies in HIV Patients

Broadly Neutralizing Antibodies in HIV Patients

By | September 28, 2016

Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.

0 Comments

image: Antibodies Prevent HIV Infection in Monkeys

Antibodies Prevent HIV Infection in Monkeys

By | April 29, 2016

Infusing anti-HIV antibodies provides macaques with protection against infection for up to six months, according to a study.

0 Comments

image: Why an HIV Vax Only Works for Some

Why an HIV Vax Only Works for Some

By | July 15, 2015

Scientists identify a human leukocyte antigen gene linked to immune protection from HIV following vaccination.

1 Comment

image: Contributors

Contributors

By | May 1, 2015

Meet some of the people featured in the May 2015 issue of The Scientist.

0 Comments

image: Hiding in the Haystack

Hiding in the Haystack

By | May 1, 2015

Encouraging developments in HIV research

0 Comments

image: HIV Structural Studies Undermine Prior Work

HIV Structural Studies Undermine Prior Work

By | November 4, 2013

New research on the structure of the surface protein the virus uses to infiltrate human cells clashes with an earlier paper’s findings, causing some scientists to call for a retraction.

0 Comments

image: Week in Review: April 1-5

Week in Review: April 1-5

By | April 5, 2013

Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine

0 Comments

image: Roadmap to an HIV Vaccine

Roadmap to an HIV Vaccine

By | April 3, 2013

Researchers track the evolution of HIV in a single patient to understand what drives the production of broadly neutralizing antibodies.

0 Comments

image: HIV Evolves Vulnerability

HIV Evolves Vulnerability

By | October 22, 2012

In mutating to evade immune detection, HIV becomes susceptible to detection by different antibodies, suggesting new strategies for vaccination.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech